Group Companies Commend 2016 Advanced
Release time:
2020-08-14
Group Company Commends 2016 Advanced
News 1# September 20 Afternoon, Group Company Held 2016 Summary Commendation Conference. While reviewing the work of the previous year and making arrangements for the work of 2017 , ceremoniously commend 2016 advanced collectives and individuals, and sign 2017 economic responsibility system with professional companies and directly affiliated enterprises. Yu Jianhong, general manager of
Group Company, made a work report entitled "Grasp the Trend, Meet the Challenge and Create New Brilliance" at the conference. In 2016 , according to the company's five-year development plan, all enterprises carried out various operation and management work in an orderly manner around the general policy of "innovation, integration, promotion and development", and achieved good business performance. Yu Jianhong seizes the opportunity and strives to find new investment and development projects; in-depth development of various management integrations to continuously improve the management level; technological innovation and technological transformation have achieved significant results; strengthen marketing management and market expansion to achieve steady sales growth; education and training Progress has been made in the construction of a talent team; actively promote the establishment of safety and environmental protection accident-free factories; strengthen the construction of corporate culture and actively support party, labor, and league activities; in eight aspects, such as the effective improvement of corporate image and influence, a systematic summary and review of the work of 2016 was made.
After a comprehensive analysis of the current national economic situation, policies and changing trends in the company's related industries, Yu Jianhong proposed the company's key work in 2017 . That is: improve development ideas and promote the development of the main business; further improve management and enhance the core competitiveness of enterprises; strengthen technological innovation and improve the development system; promote safety and environmental protection management to a higher level; control quasi-market trends and actively respond to market changes; strengthen human resources Management, continuously improve the quality of all employees; further strengthen the construction of corporate culture, unify concepts and values.
2017 is the year of the rooster in the lunar calendar. In the eyes of the ancients, the chicken has five virtues, namely, literature, martial arts, courage, benevolence, and faith, so it has always been a symbol of auspiciousness, peace, and elimination of evil spirits. At the end of the general manager's report, Yu Jianhong hopes that all the cadres and employees of the peak will also take these "five virtues" as their code of conduct in the new year: Wen, uphold the spirit of the peak and the concept of development, unify the thinking, and implement the company's various management measures in place; Wu, strengthen study, strive to improve their own quality and working ability, and enhance the management level of enterprises and the market competitiveness of products. Courage, dare to innovate, dare to open up, dare to overcome difficulties; benevolence, people-oriented, one heart and one mind, unity and cooperation; trust, integrity, integrity management, integrity management. He hopes that all cadres and employees will unite and face future challenges together.
Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, read out the list of advanced collectives and individuals at the group company level in 2016 at the conference. In a warm and cheerful atmosphere, the company's advanced dress red hanging color on stage to receive the award. Zhou Jiping, representative of advanced enterprises and general manager of Yunnan Jianfeng Cement Company, Fu Senqiang, representative of advanced teams and head of western medicine purchasing group of Jinhua Pharmaceutical Company, Luo Yubo, representative of outstanding employees and Yunnan Jianfeng Cement Company, Ma Jie, representative of rookie employees and Daye Jianfeng Cement Company, respectively took the stage to speak, reviewing their work in the past year, putting forward future ideas and expressing their determination to make new and greater contributions to the Jianfeng cause. At the
meeting, General Manager Yu Jianhong, on behalf of the Group Company, successively signed the 2017 economic responsibility system with Yunnan Jianfeng, Daye Jianfeng, Pharmaceutical Company, International Trade Company, Cable Company and Health Technology Company. At the end of the
meeting, Jiang Xiaomeng, secretary of the party Committee and chairman of the group company, made a concluding speech on the topic of "continuously improving the competitiveness of the organization and making persistent efforts to do all the work in 2017 ". he expressed his gratitude to the peak employees for their efforts in the past year, fully affirmed the achievements made, and congratulated the advanced collectives and individuals who were commended. He hopes that all employees will continue to work hard in the new year, actively promote the sustained and healthy development of the peak, and convey New Year greetings and blessings to all employees who work hard for the peak cause through the conference (details are published separately). (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31